SABS
SAB Biotherapeutics, Inc.Company with tickers: SABS, SABSW
CIK
1833214
CUSIP
78397T202
Shares Outstanding
76,464,094
13F Activity (30d)
78 filings
78 filers
Price
$3.81
Market Cap
$291.33M
P/E Ratio
-4.82
EPS (Diluted)
$-0.79
52W High
$6.60
52W Low
$1.60
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $19,997,736 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Research & Development | $13,397,977 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Operating Income | $-19,997,736 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Net Income | $-18,868,885 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $-0.35 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $-0.35 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |